Skip to content

Multi-omics molecular typing of colorectal cancer and its application in precise diagnosis and therapy

Multi-omics molecular typing of colorectal cancer and its application in precise diagnosis and therapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063600
Enrollment
Unknown
Registered
2022-09-13
Start date
2022-09-12
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

observation group:molecular testing

Sponsors

Yangpu Hospital, Tongji University School of Medicine, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18–70 years with no sex restriction; 2. Patients were pathologically diagnosed with colorectal adenocarcinoma and received colorectal surgery at Yangpu Hospital from January 2015 to December 2020. All colorectal cancers were confirmed histologically. Tumor were staged according to TNM classification (Version 8.0); 3. Patients had complete clinical data.

Exclusion criteria

Exclusion criteria: 1. Patients are unable to cooperate with follow-up; 2.Patients' study samples or data were incomplete.

Design outcomes

Primary

MeasureTime frame
accuracy;sensitivity;specificity;

Countries

China

Contacts

Public ContactErjiang Tang
tangerjiang1988051@163.com18217113135

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026